Tyr783

Site Information
FTDkAAsyTEEDENH SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 10887912

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 )
Disease tissue studied:	HER2 positive breast cancer ( 1 ) , lung cancer ( 2 ) , non-small cell lung adenocarcinoma ( 2 )
Relevant cell line - cell type - tissue:	293 (epithelial) [EphB2 (human), transfection] ( 3 ) , breast ( 1 ) , lung ( 2 )

Upstream Regulation
Treatments:	ephrin_B1 ( 3 )

References
1	Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 27251275 Curated Info
2	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info
3	Jørgensen C, et al. (2009) Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 326, 1502-9 20007894 Curated Info
4	MS Claus Jorgensen dataset-Toronto Curated Info